MMP9 and pancreatic neoplasm: Additionally, down-regulation of the PI3K/Akt pathway was demonstrated to be involved in α-mangostin-reduced viability, EMT, MMP-2/MMP-9 expression, and invasion in BxPc-3 and Panc-1 pancreatic cancer cells [20].